In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management. Cutaneous lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results